Product Images Droxidopa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Droxidopa NDC 0832-0720 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - droxipoda 01

Chemical Structure - droxipoda 01

The provided text is not sufficient to generate a useful description. It only contains the abbreviation "OH" and a newline character.*

Figure 1 - droxipoda 02

Figure 1 - droxipoda 02

This is a report of a clinical trial evaluating the mean change in dizziness in a double-blind treatment phase for a medication called Droxidopa. The baseline value was 5.1 and there were two groups. However, there is not enough information to determine the efficacy of the medication or any other relevant details regarding the trial.*

Figure 2 - droxipoda 03

Figure 2 - droxipoda 03

The given text represents a graph showing the percentage of subjects with improved symptoms of orthostatic hypotension (OHSA) before and after treatment with drugs. The horizontal axis shows the scale of improvement in OHSA Question 1, while the vertical axis represents the percentage of subjects. The graph shows that the drug Droxidopa has a better success rate than the placebo drug in improving the symptoms of the participants.*

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label - droxipoda 04

PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label - droxipoda 04

This is a medicine called DIG D] E]. Each capsule contains 100 mg of Droxidopa. It is a prescription-only medicine and the recommended dosage is mentioned in the package insert. It should be stored at a temperature between 20°C to 25°C and should be protected from light. The medicine should be dispensed in a light-resistant container and should not be used if the printed seal under the cap is broken or missing. The medicine is manufactured by Upshear-Smith Laboratories in Maple Grove, MN, and is a product of India made in New Zealand. The label also mentions the GTIN number, expiry date, lot number, and a serial number, along with copyright information.*

PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle Label - droxipoda 05

PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle Label - droxipoda 05

This is a prescription drug called DROXIDOPA, which comes in a bottle with 90 capsules. Each capsule contains 200mg of Droxidopa. The recommended dosage is given in the package insert. It should be stored between 20-25°C, and kept away from children. This product is manufactured by Upsher-Smith Laboratories in Maple Grove, Minnesota, and is a product of India, made in New Zealand. It comes with a barcode and expiration date printed on the label.*

PRINCIPAL DISPLAY PANEL - 300 mg Capsule Bottle Label - droxipoda 06

PRINCIPAL DISPLAY PANEL - 300 mg Capsule Bottle Label - droxipoda 06

This is a prescription drug containing Droxidopa in the form of capsules. Each capsule contains 300 mg of the drug. The usual dosage information can be found in the package insert. It is recommended to store the drug in a container at a temperature range of 20° to 25°C (68° to 77°F). The drug is manufactured by Upsher-Smith Laboratories, LLC, in Maple Grove, MN 55369, and it is a product of India and made in New Zealand. The details of expiration and lot number are provided. Keep this drug in a tight, light-resistant container, and away from children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.